tiprankstipranks
Sierra Oncology (SRRA)
NASDAQ:SRRA
Holding SRRA?
Track your performance easily

Sierra Oncology (SRRA) Income Statement

0 Followers

Sierra Oncology Income Statement

Last quarter (Q ), Sierra Oncology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Sierra Oncology's net income was $-27.93M. See Sierra Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-$ 0.00$ 300.00K$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 102.65M$ 94.58M$ 65.24M$ 66.99M$ 55.42M$ 42.62M
Operating Income
$ -102.65M$ -94.58M$ -64.94M$ -66.99M$ -55.42M$ -42.62M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -107.00K$ -77.00K$ -15.82M$ -21.44M$ 1.78M$ 760.00K
Pretax Income
$ -102.76M$ -94.66M$ -80.76M$ -88.44M$ -53.64M$ -41.86M
Tax Provision
$ -85.00K$ -3.00K$ 142.00K$ -160.00K$ -302.00K$ 156.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -102.67M$ -94.66M$ -80.90M$ -88.28M$ -53.34M$ -42.02M
Basic EPS
$ -6.77$ -7.14$ -7.70$ -30.30$ -30.16$ -33.68
Diluted EPS
$ -6.77$ -7.14$ -7.70$ -30.30$ -30.16$ -33.68
Basic Average Shares
$ 62.29M$ 13.25M$ 10.51M$ 2.91M$ 1.77M$ 1.25M
Diluted Average Shares
$ 62.29M$ 13.25M$ 10.51M$ 2.91M$ 1.77M$ 1.25M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
$ -1.44$ -6.17$ -5.12$ -702.40--
Reported Normalized Diluted E P S
$ -1.44$ -6.17$ -5.12$ -702.40--
Rent Expense Supplemental
------
Total Expenses
$ 102.65M$ 94.58M$ 65.24M$ 66.99M$ 55.42M$ 42.62M
Net Income From Continuing And Discontinued Operation
$ -102.67M$ -94.66M$ -80.90M$ -88.28M$ -53.34M$ -42.02M
Normalized Income
$ -102.67M$ -94.66M$ -69.05M$ -67.39M$ -53.34M$ -42.02M
Interest Expense
------
EBIT
$ -102.65M$ -94.58M$ -64.94M$ -66.99M$ -55.42M$ -42.62M
EBITDA
$ -102.30M$ -94.28M$ -64.70M$ -66.91M$ -55.31M$ -42.36M
Currency in USD

Sierra Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis